Outcomes of endoscopic and surgical resection for a second primary cancer in the residual cervical esophagus after thoracic esophagectomy.

Patients who have received subtotal esophagectomy for thoracic esophageal cancer must be closely monitored for second primary malignancies. The purpose of this study is to review and assess patients who developed a second primary esophageal cancer in the residual cervical esophagus. Between 1996 and 2010, 10 patients were diagnosed in our hospital with esophageal squamous cell cancer in the residual cervical esophagus after undergoing thoracic esophagectomy and were treated with endoscopic or surgical resection. Data from these patients were reviewed retrospectively. Seven of the 10 patients (70%) had multiple primary carcinoma lesions at the time of their esophagectomy. A second primary cancer in the residual cervical esophagus was detected in eight patients during follow-up endoscopic examinations while the patients were still asymptomatic. Seven of the patients underwent endoscopic resection for a superficial cancer. None of those patients experienced any complications, and all are currently alive and cancer-free. The remaining three patients underwent resection of the cervical esophagus with regional lymph node dissection. Two of those patients experienced severe complications; one subsequently died (hospital death) from pneumonia, 12 months after surgery, while the other died from recurrence of his cancer. The third patient is alive and cancer-free. Early detection of a second primary malignancy in the residual cervical esophagus followed by endoscopic resection is the best treatment strategy for patients who previously received subtotal esophagectomy for thoracic esophageal cancer. Surgical resection puts patients at high risk of mortality or morbidity.
AuthorsS Usami, S Motoyama, T Matsuhashi, M Jin, K Maruyama, Y Sato, K Yoshino, T Nakatsu, H Saito, Y Minamiya, R Saito, H Ohnishi, J Ogawa
JournalDiseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E (Dis Esophagus) Vol. 25 Issue 3 Pg. 228-34 (Apr 2012) ISSN: 1442-2050 [Electronic] Australia
PMID21895851 (Publication Type: Journal Article)
Copyright© 2011 Copyright the Authors. Journal compilation © 2011, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell (pathology, surgery, therapy)
  • Chemoradiotherapy, Adjuvant
  • Esophageal Neoplasms (surgery)
  • Esophagectomy (adverse effects)
  • Esophagoscopy
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasms, Second Primary (pathology, surgery, therapy)
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: